Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib and Everolimus or Temozolomide in Pediatric and Young Adult Patients With High-Grade Glioma
NCT05843253Phase 2Recruiting
- Sponsor
- Nationwide Children's Hospital
- Start
- Aug 2024
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ribociclib in glioma, diffuse intrinsic pontine glioma (DIPG), diffuse hemispheric glioma (DHG), sponsored by Nationwide Children's Hospital. Started Aug 2024; status: recruiting.
02
Drugs
ribociclib
03
Conditions
gliomadiffuse intrinsic pontine glioma (DIPG)diffuse hemispheric glioma (DHG)
Beyond the preview
Go deeper on NCT05843253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05843253.